To cycle or not to cycle: a critical decision in cancer

Nature Reviews. Cancer
M Malumbres, M Barbacid

Abstract

Tumour cells undergo uncontrolled proliferation, yet tumours most often originate from adult tissues, in which most cells are quiescent. So, the proliferative advantage of tumour cells arises from their ability to bypass quiescence. This can be due to increased mitogenic signalling and/or alterations that lower the threshold required for cell-cycle commitment. Understanding the molecular mechanisms that underlie this commitment should provide important insights into how normal cells become tumorigenic and how new anticancer strategies can be devised.

References

Sep 24, 1992·Nature·T JacksR A Weinberg
Jan 1, 1992·Annual Review of Biochemistry·C Norbury, P Nurse
Nov 3, 1989·Science·L H Hartwell, T A Weinert
Apr 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·A B Pardee
Sep 1, 1994·European Journal of Biochemistry·J VeselýS Leclerc
Mar 1, 1994·Molecular and Cellular Biology·M Meyerson, E Harlow
Dec 24, 1993·Science·S van den Heuvel, E Harlow
Jan 1, 1997·Molecular and Cellular Biology·D M Bortner, M P Rosenberg
Apr 1, 1997·Genes & Development·J LaBaerE Harlow
May 19, 1997·Biochemical and Biophysical Research Communications·M R SmithD K Ferris
Jun 1, 1997·Genes & Development·R J SheaffB E Clurman
Jan 13, 1998·Current Opinion in Cell Biology·M D Planas-Silva, R A Weinberg
Jan 1, 1997·Annual Review of Cell and Developmental Biology·D O Morgan
Apr 1, 1998·Nature·D P CahillB Vogelstein
May 23, 1998·The Journal of Cell Biology·J BrugarolasT Jacks
Jun 17, 1998·Genes & Development·E Robanus-MaandagH te Riele
Jun 23, 1998·Trends in Genetics : TIG·G Mulligan, T Jacks
Aug 11, 1998·Frontiers in Bioscience : a Journal and Virtual Library·M Malumbres, A Pellicer
Mar 11, 1999·Current Opinion in Genetics & Development·M D Garrett, A Fattaey
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y N ChenW G Kaelin
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·M S ParkA Koff
Jun 25, 1999·Cell·Y GengP Sicinski
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts

❮ Previous
Next ❯

Citations

Jun 10, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Guang YangShiguang Zhao
Sep 2, 2004·Journal of Cancer Research and Clinical Oncology·Gerhard EisenbrandStephan Muehlbeyer
Sep 27, 2008·Breast Cancer Research and Treatment·Cheng LuHongbing Shen
Jun 30, 2005·Cancer Metastasis Reviews·Ruth Halaban
Mar 19, 2013·Journal of Molecular Histology·Renato Luiz Maia NogueiraSilvia Helena Barem Rabenhorst
Jun 23, 2006·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Marcos Malumbres
Apr 25, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jianming LiuXinmin Liu
Jun 19, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Sheng GaoCheng Lu
Mar 5, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Junfang WuAlan I Faden
Mar 18, 2004·Bioorganic & Medicinal Chemistry Letters·Marie GompelLaurent Meijer
Mar 23, 2005·Bioorganic & Medicinal Chemistry Letters·Chafiq HamdouchiHarold B Brooks
Jun 12, 2004·Clinical Oncology : a Journal of the Royal College of Radiologists·L M KennyP M Price
May 13, 2005·Mechanisms of Ageing and Development·Young Hoon SungHan-Woong Lee
Mar 17, 2004·Seminars in Cancer Biology·Paul M Campbell, Channing J Der
Apr 21, 2005·Seminars in Cell & Developmental Biology·Julie P I Welburn, Jane A Endicott
Apr 9, 2005·Experimental Cell Research·Paulo Matos, Peter Jordan
Jun 14, 2003·Pharmacology & Therapeutics·L ReddyK D Bhoola
Jun 14, 2003·Pharmacology & Therapeutics·Jamila K AdamKanti D Bhoola
Sep 19, 2002·Trends in Pharmacological Sciences·Marie KnockaertLaurent Meijer
Jul 23, 2003·Trends in Pharmacological Sciences·Paula M ChecchiHarish C Joshi
Feb 8, 2003·Current Opinion in Genetics & Development·Sunil R Hingorani, David A Tuveson
Aug 17, 2002·Bioorganic & Medicinal Chemistry Letters·Gail E AtkinsonWeng C Chan
Jan 1, 2004·The Lancet Oncology·Charles Swanton
Jan 14, 2003·Trends in Molecular Medicine·Margaret M Manson
Jul 2, 2008·Expert Reviews in Molecular Medicine·Abde M Abukhdeir, Ben Ho Park
Feb 5, 2011·ACS Chemical Biology·Stephane BetziErnst Schönbrunn
Apr 23, 2013·Journal of Medicinal Chemistry·Ernst SchonbrunnGunda I Georg
Mar 5, 2011·Journal of Natural Products·You-Jin KangSang Kook Lee
Jan 10, 2012·Cell Death and Differentiation·E ManchadoM Malumbres
May 11, 2011·Cell Research·Fang WangJun-Wu Zhang
Sep 9, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Maria BaiPanagiotis Kanavaros
Mar 28, 2008·Nature Cell Biology·Guang YaoLingchong You
Aug 3, 2004·Nature Medicine·Bert Vogelstein, Kenneth W Kinzler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.